Powchik Peter Insider Trades

Insider Trading History

Track insider trading activity for Powchik Peter. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Vaxxinity
Vaxxinity VAXX
Director
Holding Value $16 159,744 shares
Last Trade
Oct 02, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$203k 159,744 shares
$1.27
$0.00
Vaxxinity
Vaxxinity VAXX
Director
Holding Value $13.2 132,352 shares
Last Trade
Jun 20, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$292k 132,352 shares
$2.21
$0.00
Vaxxinity
Vaxxinity VAXX
Director
Holding Value $12.9 129,187 shares
Last Trade
Jun 21, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$270k 129,187 shares
$2.09
$0.00
Vaxxinity
Vaxxinity VAXX
Director
Holding Value $9.42 94,186 shares
Last Trade
Mar 31, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$405k 94,186 shares
$4.30
$0.00
Regeneron Pharmaceuticals
Regeneron Pharmaceuticals REGN
SVP Clinical Development & Reg
Holding Value $3.09M 5,000 shares
Last Trade
Dec 16, 2016 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.91M 5,000 shares
$381.92
$618.95
Regeneron Pharmaceuticals
Regeneron Pharmaceuticals REGN
SVP Clinical Development & Reg
Holding Value $1.52M 2,459 shares
Last Trade
May 16, 2016 Purchase (Gift)Shares transferred as a gift rather than bought or sold for cash.
$964k 2,459 shares
$391.95
$618.95
Regeneron Pharmaceuticals
Regeneron Pharmaceuticals REGN
SVP Clinical Development & Reg
Holding Value $1.52M 2,459 shares
Last Trade
May 16, 2016 Sale (Gift)Shares transferred as a gift rather than bought or sold for cash.
$1.93M 4,918 shares
$391.95
$618.95
Regeneron Pharmaceuticals
Regeneron Pharmaceuticals REGN
SVP Clinical Development & Reg
Holding Value $0 0 shares
Last Trade
Dec 16, 2015 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.08M 1,921 shares
$559.67
$618.95
Regeneron Pharmaceuticals
Regeneron Pharmaceuticals REGN
SVP Clinical Development & Reg
Holding Value $11M 17,742 shares
Last Trade
Dec 16, 2015 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.08M 1,921 shares
$559.67
$618.95
Regeneron Pharmaceuticals
Regeneron Pharmaceuticals REGN
SVP Clinical Development & Reg
Holding Value $15.5M 25,000 shares
Last Trade
Dec 16, 2015 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$13.9M 25,000 shares
$555.67
$618.95
Regeneron Pharmaceuticals
Regeneron Pharmaceuticals REGN
SVP Clinical Development & Reg
Holding Value $23.5M 37,901 shares
Last Trade
Aug 14, 2015 Sale (Open Market)Shares sold on the open market or in a private sale.
$13.5M 23,485 shares
$573.38
$618.95
Regeneron Pharmaceuticals
Regeneron Pharmaceuticals REGN
SVP Clinical Development & Reg
Holding Value $27.4M 44,234 shares
Last Trade
Aug 13, 2015 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$21.4M 36,876 shares
$579.35
$618.95
Regeneron Pharmaceuticals
Regeneron Pharmaceuticals REGN
SVP Clinical Development & Reg
Holding Value $18.6M 30,000 shares
Last Trade
Aug 13, 2015 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$34.7M 60,361 shares
$574.10
$618.95
Regeneron Pharmaceuticals
Regeneron Pharmaceuticals REGN
SVP Clinical Development & Reg
Holding Value $28.7M 46,299 shares
Last Trade
Aug 13, 2015 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$34.7M 60,361 shares
$574.10
$618.95
Regeneron Pharmaceuticals
Regeneron Pharmaceuticals REGN
SVP Clinical Development & Reg
Holding Value $12.5M 20,133 shares
Last Trade
Jan 02, 2015 Sale (Open Market)Shares sold on the open market or in a private sale.
$4.48M 10,822 shares
$414.08
$618.95
Regeneron Pharmaceuticals
Regeneron Pharmaceuticals REGN
SVP Clinical Development & Reg
Holding Value $23M 37,079 shares
Last Trade
Dec 31, 2014 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$10.3M 25,000 shares
$410.25
$618.95
Regeneron Pharmaceuticals
Regeneron Pharmaceuticals REGN
SVP Clinical Development & Reg
Holding Value $20.2M 32,560 shares
Last Trade
Dec 31, 2014 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$5.85M 14,178 shares
$412.78
$618.95
Regeneron Pharmaceuticals
Regeneron Pharmaceuticals REGN
SVP Clinical Development & Reg
Holding Value $22.1M 35,711 shares
Last Trade
Dec 31, 2014 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$10.3M 25,000 shares
$410.25
$618.95
Regeneron Pharmaceuticals
Regeneron Pharmaceuticals REGN
SVP Clinical Development & Reg
Holding Value $0 0 shares
Last Trade
Dec 19, 2014 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.4M 3,264 shares
$427.64
$618.95
Regeneron Pharmaceuticals
Regeneron Pharmaceuticals REGN
SVP Clinical Development & Reg
Holding Value $6.63M 10,711 shares
Last Trade
Dec 19, 2014 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.4M 3,264 shares
$427.64
$618.95

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up